Literature DB >> 16249826

Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients.

Norma Nardi1, Pilar Brito-Zerón, Manuel Ramos-Casals, Sira Aguiló, Ricard Cervera, Miguel Ingelmo, Josep Font.   

Abstract

The aim of this study was to analyze the prevalence and clinical significance of circulating auto-antibodies against nuclear and non-nuclear antigens in a large cohort of Spanish patients with primary Sjögren's syndrome (SS). We studied 335 patients diagnosed with primary SS seen consecutively in our department since 1994 and tested for anti-nuclear antibodies (ANA), anti-Ro/SS-A, anti-La/SS-B, anti-Sm, anti-ribonucleoprotein (anti-RNP), anti-smooth muscle antibodies (anti-SMA), anti-parietal cell antibodies (anti-PCA), anti-liver-kidney microsome type-1 (anti-LKM-1) antibodies and anti-mitochondrial antibodies (AMA). ANA were detected in 278 (83%) patients. The association of positive ANA with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies reached statistical significance at a titre of ANA >1/80 (p<0.001), while the presence of anti-Sm and anti-RNP was associated with positive ANA at a titre > or =1/320 (p=0.037 for Sm and p=0.016 for RNP). ANA titres correlated with the number of positive antibodies against specific nuclear antigens (p<0.001) but not with the number of positive antibodies against non-nuclear antigens. We found positive anti-Ro/SS-A antibodies in 111 (33%) patients, anti-La/SS-B in 78 (23%), anti-RNP in 8 (2%) and anti-Sm in 4 (1%). Anti-SMA antibodies were detected in 208 (62%) patients, with no significant associations with clinical or analytical SS features, while anti-PCA antibodies were found in 90 (27%) patients and were associated with a higher prevalence of thyroiditis and liver involvement. AMA were detected in 28 (8%) patients, although only 14 presented clinical and/or analytical evidence of liver involvement. No patient presented anti-LKM antibodies. ANA play a central role in the immunological expression of primary SS, due to their frequency and close association with the underlying presence of one or more anti-ENA antibodies. Positivity for antibodies against non-nuclear antigens such as anti-PCA and AMA suggests an association with some organ-specific autoimmune diseases (thyroiditis and primary biliary cirrhosis), while the presence of anti-SMA, in spite of their high prevalence, has no clinical significance in primary SS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249826     DOI: 10.1007/s10067-005-0059-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study.

Authors:  K Asmussen; V Andersen; G Bendixen; M Schiødt; P Oxholm
Journal:  J Intern Med       Date:  1996-06       Impact factor: 8.989

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

5.  Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.

Authors:  E L Alexander; F C Arnett; T T Provost; M B Stevens
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

6.  Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.

Authors:  B K Davidson; C A Kelly; I D Griffiths
Journal:  Rheumatology (Oxford)       Date:  1999-03       Impact factor: 7.580

7.  Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.

Authors:  D Alarcón-Segovia; M H Cardiel
Journal:  J Rheumatol       Date:  1989-03       Impact factor: 4.666

8.  Serological profiles in subgroups of patients with Sjögren's syndrome.

Authors:  M N Manoussakis; A G Tzioufas; P J Pange; H M Moutsopoulos
Journal:  Scand J Rheumatol Suppl       Date:  1986

Review 9.  Primary biliary cirrhosis.

Authors:  Jayant A Talwalkar; Keith D Lindor
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

10.  Primary Sjögren's syndrome associated with chronic atrophic gastritis and pernicious anemia.

Authors:  J Pedro-Botet; J Coll; S Tomás; J C Soriano; J Gutiérrez-Cebollada
Journal:  J Clin Gastroenterol       Date:  1993-03       Impact factor: 3.062

View more
  28 in total

1.  Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.

Authors:  Chao-Jun Hu; Guang Song; Wei Huang; Guo-Zhen Liu; Chui-Wen Deng; Hai-Pan Zeng; Li Wang; Feng-Chun Zhang; Xuan Zhang; Jun Seop Jeong; Seth Blackshaw; Li-Zhi Jiang; Heng Zhu; Lin Wu; Yong-Zhe Li
Journal:  Mol Cell Proteomics       Date:  2012-05-30       Impact factor: 5.911

Review 2.  Autoantibodies in Sjögren's Syndrome.

Authors:  Anum Fayyaz; Biji T Kurien; R Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

Review 3.  The Diagnosis and Treatment of Sjögren's Syndrome.

Authors:  Ana-Luisa Stefanski; Christian Tomiak; Uwe Pleyer; Thomas Dietrich; Gerd Rüdiger Burmester; Thomas Dörner
Journal:  Dtsch Arztebl Int       Date:  2017-05-26       Impact factor: 5.594

Review 4.  Primary biliary cirrhosis: what do autoantibodies tell us?

Authors:  Chao-Jun Hu; Feng-Chun Zhang; Yong-Zhe Li; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

5.  Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren's syndrome patients using single-cell analysis.

Authors:  Alexandria Voigt; Katherine Bohn; Sukesh Sukumaran; Carol M Stewart; Indraneel Bhattacharya; Cuong Q Nguyen
Journal:  Clin Immunol       Date:  2018-04-19       Impact factor: 3.969

6.  Prognostic value of Sjögren's syndrome autoantibodies.

Authors:  R Hal Scofield; Anum Fayyaz; Biji T Kurien; Kristi A Koelsch
Journal:  J Lab Precis Med       Date:  2018-10-30

Review 7.  [Interdisciplinary point of contact between rheumatology and pneumology].

Authors:  J Hermann; G Kovacs; S Scheidl
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

8.  Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.

Authors:  Gary L Norman; Chen-Yen Yang; Heather P Ostendorff; Zakera Shums; Mark J Lim; Jinjun Wang; Amany Awad; Gideon M Hirschfield; Piotr Milkiewicz; Donald B Bloch; Kenneth J Rothschild; Christopher L Bowlus; Iannis E Adamopoulos; Patrick S C Leung; Harry J Janssen; Angela C Cheung; Catalina Coltescu; M Eric Gershwin
Journal:  Liver Int       Date:  2014-10-10       Impact factor: 5.828

9.  DNase1 exon2 analysis in Tunisian patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren syndrome and healthy subjects.

Authors:  Salima Belguith-Maalej; Hassen Hadj-Kacem; Neila Kaddour; Zouhir Bahloul; Hammadi Ayadi
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

10.  [Vasculitic leg ulcers in primary Sjogren syndrome].

Authors:  M Gwosdz; A Körber; U Hillen; J Dissemond
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.